Top 5 Dividend Stocks To Invest In Right Now: Abbott Laboratories(ABT)
Abbott Laboratories engages in the discovery, development, manufacture, and sale of health care products worldwide. The company offers adult and pediatric pharmaceuticals for rheumatoid and psoriatic arthritis, ankylosing spondylitis, psoriasis, and Crohn's disease; dyslipidemia; HIV infection; prostate cancer, endometriosis and central precocious puberty, and anemia caused by uterine fibroids; respiratory syncytial virus; adult males who have low or no testosterone; secondary hyperparathyroidism; hypothyroidism; and pancreatic exocrine insufficiency, as well as anesthesia products. It also provides diagnostic products, such as immunoassay systems; chemistry systems; assays used for screening and/or diagnosis for drugs of abuse, cancer, therapeutic drug monitoring, fertility, physiological, and infectious diseases; instruments that automate the extraction, purification, and preparation of DNA and RNA from patient samples, and detect and measure infections agents; genomic-b ased tests; hematology systems and reagents; and point-of-care diagnostic systems and tests for blood analysis. In addition, the company offers a line of pediatric and adult nutritional products. Further, it provides coronary, endovascular, vessel closure, and structural heart devices, such as drug-eluting stent systems, coronary metallic stents, balloon dilatation products, coronary guidewires, vessel closure devices, carotid stent systems, percutaneous valve repair systems, and drug eluting bioresorbable vascular products. Additionally, the company provides blood glucose monitoring meters, test strips, data management software, and accessories for people with diabetes; and medical devices for the eye, including cataract surgery, lasik surgery, contact lens, and dry eye products, as well as branded generic pharmaceutical products. Abbott primarily serves retai! lers, wholesalers, hospitals, and health care facilities. Abbott was founded in 1888 and is headquartered in Abbott Park, Illinois.Advisors' Opinion:
- [By Jim Jubak]
Fourth quarter earnings and guidance for 2014, announced on January 22, make it clear that Abbott Laboratories (ABT) is a second half story for 2014.
- [By MONEYMORNING]
And it's not just because you were able to cash in on our recommendation of Abbott Laboratories Inc. (NYSE: ABT), whose subsequent breakup into two companies has so far resulted in gains of 27% and 47%.
- [By J. Royden Ward]
Founded in 1888, Abbott Laboratories (ABT) is the leading provider of blood screening products used to detect pregnancy, heart disease, prostate cancer, hepatitis, HIV, sports doping, and other medical conditions.
- [By Kelley Wright]
Abbott Laboratories (ABT) is a well-established, global health care company with an S&P "A" Quality Ranking. Fiscal year free operating cash flow is three times its dividend, which is no surprise for this long-time Dividend Aristocrat. A solid anchor position for any portfolio.
source from Top Stocks Blog:http://www.topstocksblog.com/top-5-dividend-stocks-to-invest-in-right-now.html